4//SEC Filing
WITTE OWEN N. 4
Accession 0001737287-25-000072
CIK 0001737287other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 9:03 PM ET
Size
313.0 KB
Accession
0001737287-25-000072
Insider Transaction Report
Form 4
WITTE OWEN N.
Director
Transactions
- Award
Restricted Stock Unit
2025-06-18+95,400→ 95,400 total→ Common Stock (95,400 underlying)
Footnotes (1)
- [F1]Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Company Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. The reporting person has elected to defer the receipt of Common Stock upon the vesting of their RSUs pursuant to the Company's Non-Employee Director Compensation Policy until earlier of (i) 30 days following separation from continuous service with the company and (ii) a change in control of the Company.
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001700969
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 9:03 PM ET
- Size
- 313.0 KB